Actively Recruiting
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
Led by Boston Children's Hospital · Updated on 2026-04-24
288
Participants Needed
1
Research Sites
195 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
According to the American Society of Anesthesiologists (ASA) fasting guideline for patients undergoing elective surgery, the 2-hour fasting period is suggested for clear oral fluid (including water, pulp-free juice and tea or coffee without milk). This guideline does not give any suggestions for proper volume of clear oral fluid intake. This study is a prospective randomized control trials in children aged 13 through 17 years who are scheduled for an elective upper GI endoscopy procedure in the Gastroenteral Procedure Unit (GPU) at Boston Children's Hospital. The participants will be randomly assigned into one of four groups: Group 1 will consume 3 ml/kg of clear fluid by mouth at 2-hour period before surgical scheduled time, Group 2 will consume 5 ml/kg, Group 3 will consume 7 ml/kg, and Group 4 will consume 10 ml/kg. The investigators plan to recruit 72 patients in each group and 288 patients for the whole study. Research team will collect patient's demographic data, vital signs, information about their EGD procedure. Then actual volume of the stomach content and acidity will be measured from the content that is suctioned from patient's stomach during upper GI endoscopy procedure. The investigators believe that the information from this study will help establish a comprehensive NPO guideline.
CONDITIONS
Official Title
Comparison of Residual Gastric Volume Between Children Who Drink Different Clear Oral Fluid Volume
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ASA classification I and II
- Aged 13 to 17 years
- Inpatient cases or first outpatient cases
- Scheduled for elective esophago-gastro-duodenoscopy (EGD) procedure
- Participant, family, or guardian fluent in English
You will not qualify if you...
- Emergency EGD procedures
- Active upper gastrointestinal bleeding
- Received preoperative oral medication
- Diagnosed with GERD, achalasia, or suspected gastroparesis such as uncontrolled diabetes or end-stage kidney disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 01225
Actively Recruiting
Research Team
S
Sirirat Rattanaarpa, MD
CONTACT
P
Patcharee Sriswasdi, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here